Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-11-22

FDA Approved: ANASTROZOLE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Anastrozole submitted by Teva Pharmaceuticals USA, Inc. under ANDA078058, marking an additional approval to the prod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anastrozole (Anastrozole)

Snippet

SUPPL AP for ANASTROZOLE (ANASTROZOLE)